New Key Statistics Module, Z-Score and F-Score
NAS:TNXP Key Ratios
| Market Cap $ M | 61.64 |
| Enterprise Value $ M | 47.76 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 0.69 |
| Price/Sales | 0.09 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 11.00 |
| EPS (TTM) $ | -101.00 |
| Beneish M-Score | -0.32 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | 81.70 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -0.59 |
| EV-to-EBITDA | -0.62 |
| PEG | -- |
| Shares Outstanding M | 186.89 |
| Net Margin (%) | -1,197.86 |
| Operating Margin % | -716.72 |
| Pre-tax Margin (%) | -1,197.86 |
| Quick Ratio | 2.78 |
| Current Ratio | 3.33 |
| ROA % (ttm) | -113.77 |
| ROE % (ttm) | -150.01 |
| ROIC % (ttm) | -90.05 |
| Dividend Yield % | -- |
| Altman Z-Score | -12.63 |
TNXP Number of Guru Trades
TNXP Volume of Guru Trades
Gurus Latest Trades with NAS:TNXP
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:TNXP is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Tonix Pharmaceuticals Holding Corp Insider Transactions
No Available Data
News about NAS:TNXP
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers